Molecular and Cellular Biochemistry

, Volume 306, Issue 1, pp 33–42

Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors


DOI: 10.1007/s11010-007-9551-1

Cite this article as:
Cherlet, T. & Murphy, L.C. Mol Cell Biochem (2007) 306: 33. doi:10.1007/s11010-007-9551-1


Breast tumorigenesis and breast cancer progression involves the deregulation or hyperactivation of intracellular signaling proteins that leads to uncontrolled cellular proliferation, invasion and metastasis. For example, the expression and cellular responses to estogen receptor (ER) and transforming growth factor β (TGFβ) signaling pathways change during breast tumorigenesis and breast cancer progression. While the expression and activity of ER and TGFβ maybe significant in the development of breast cancer, alterations in the cross-talk between these pathways may be equally important. Autocrine and paracrine effects of TGFβ on breast cancer cell growth have been known for some time, but only recently have direct interactions between ER and TGFβ been described. The purpose of this article was to further characterize the cross-talk between ER and TGFβ, by examining ER interaction with Smad3, a downstream mediator of TGFβ signaling. Transient transfection of Cos1 cells with p3TP-lux, demonstrate that ERα and ERβ1 repress Smad3 transcriptional activity in an estradiol-dependent manner and that this effect is inhibited by antiestrogen treatment. The ERβ variants, ERβ2 and ERβ5, did not have any effect on Smad3 transcriptional activity. Further experiments attempted to characterize the molecular mechanism by which activated ER inhibits Smad3 transcriptional activity. Results indicate that ligand-bound ER does not affect Smad3 protein expression levels and that ER does not form direct protein interactions with Smad3. Transient transfection of Cos1 cells with the Ap-1 transcription factor c-Jun but not c-Fos was able to rescue the inhibitory effect of estrogen on Smad3 transcriptional activity. Based on these results, a model is proposed whereby c-Jun is limiting in its ability to act as a Smad3 co-activator in the presence of E2-bound ER, possibly due to ER sequestering c-Jun away from the Smad3 responsive promoter.


Estrogen receptors Smad 3 Transforming growth factor β c-jun Cross-talk Breast cancer 

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Manitoba Institute of Cell Biology, Department of Biochemistry & Medical GeneticsUniversity of ManitobaWinnipegCanada

Personalised recommendations